ProPharma Expands Regulatory Sciences Team in the Japan and Asia-Pacific Region with Addition of Neama Baho

August 30, 2023

Neama Baho, Associate Vice President, Regulatory Sciences Press Release Announcement

RALEIGH, NC, August 30, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of Odyssey Investment Partners, announces the expansion of its Regulatory Sciences team with the appointment of Neama Baho as Associate Vice President, Regulatory Sciences. In her new role, Baho will oversee regulatory operations in Japan and Asia-Pacific markets.

A renowned industry strategist, Baho brings 25+ years of progressive leadership experience in the international pharmaceutical industry, with over two decades specializing in regulatory affairs. Her profound expertise, spanning over 60 markets including Asia-Pacific, Latin America, and Europe, promises to be a significant asset for ProPharma's Regulatory Sciences team, broadening its presence, reach, and scale.

Matthew Weinberg, ProPharma’s President, Regulatory Sciences, said: "Neama's global leadership experience in pharmaceuticals and regulatory affairs makes her uniquely qualified to join the team and oversee ProPharma's next phase of expansion throughout Japan and Asia-Pacific. Her expertise and proven track record are vital to ensure industry leadership and operational excellence in Regulatory Sciences within the region."

Baho expressed her enthusiasm: "I am excited to join ProPharma's Regulatory Sciences team. The company's reputation for innovation and commitment to excellence seamlessly align with my professional ethos. I am eager to contribute to ProPharma's continued success in this dynamic region and look forward to leading a collaborative and cross-cultural team."

As the world's largest RCO (Research Consulting Organization), ProPharma is dedicated to delivering operational excellence, quality client outcomes, and improving the health and safety of patients worldwide. Baho’s addition to the Regulatory Sciences team underscores this commitment and positions ProPharma for continued success in the future.

###

Media Inquiries and Contacts:

Zosya Popik Vice President, Global Marketing
ProPharma
zosya.popik@propharmagroup.com

Steve Rensi Senior Director, Global Brand Strategy & Communications
ProPharma
steve.rensi@propharmagroup.com

Jason Wakeford Senior Vice President, Communications
Clarity for ProPharma
propharma@clarity.global

TAGS:

ProPharma Top 20 CRO Companies

July 26, 2023

ProPharma Recognized by PharmaTech Outlook as the World’s Premier Research Consulting Organization

RALEIGH, NC, July 26, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of Odyssey...

ProPharma Inc 5000 List of Fastest Growing Companies in America

August 15, 2023

ProPharma Recognized by Inc. 5000 List of America’s Fastest-Growing Companies

ProPharma Recognized on the Inc. 5000 List of America’s Fastest-Growing Companies After a year of Growth and Innovation, ProPharma achieved its highest rank in 20+ year history. RALEIGH, NC, August...

Helen Hall - Global Head of Clinical Data Sciences

August 2, 2023

ProPharma Announces the Appointment of Helen Hall as Global Head of Clinical Data Sciences

RALEIGH, NC, August 2, 2023, ProPharma Group (ProPharma), the leading global provider of regulatory, clinical, and compliance services for the life sciences industry, and a portfolio company of...